These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 14676301)
41. The expression of androgen receptor in triple-negative breast cancer and the effect of a traditional Chinese medicine formula on disease-free survival. Yu L; Yu Q; Xu C; Wang M; Song J; Gao X Gland Surg; 2022 Nov; 11(11):1772-1783. PubMed ID: 36518802 [TBL] [Abstract][Full Text] [Related]
42. Sex-biased adaptive immune regulation in cancer development and therapy. Schafer JM; Xiao T; Kwon H; Collier K; Chang Y; Abdel-Hafiz H; Bolyard C; Chung D; Yang Y; Sundi D; Ma Q; Theodorescu D; Li X; Li Z iScience; 2022 Aug; 25(8):104717. PubMed ID: 35880048 [TBL] [Abstract][Full Text] [Related]
43. The Other Side of the Coin: May Androgens Have a Role in Breast Cancer Risk? Chiodo C; Morelli C; Cavaliere F; Sisci D; Lanzino M Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008851 [TBL] [Abstract][Full Text] [Related]
44. Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer. Qiu P; Guo Q; Yao Q; Chen J; Lin J PLoS One; 2021; 16(11):e0254283. PubMed ID: 34797837 [TBL] [Abstract][Full Text] [Related]
45. Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals. Deng G; Wang R; Sun Y; Huang CP; Yeh S; You B; Feng C; Li G; Ma S; Chang C Cell Death Differ; 2021 Jul; 28(7):2145-2159. PubMed ID: 34127806 [TBL] [Abstract][Full Text] [Related]
46. Effects of Environmental Endocrine-Disrupting Chemicals on Female Reproductive Health. Liu Q Adv Exp Med Biol; 2021; 1300():205-229. PubMed ID: 33523436 [TBL] [Abstract][Full Text] [Related]
47. Quadruple-negative breast cancer: novel implications for a new disease. Bhattarai S; Saini G; Gogineni K; Aneja R Breast Cancer Res; 2020 Nov; 22(1):127. PubMed ID: 33213491 [TBL] [Abstract][Full Text] [Related]
48. Computational analysis of androgen receptor (AR) variants to decipher the relationship between protein stability and related-diseases. Chen F; Chen X; Jiang F; Leng F; Liu W; Gui Y; Yu J Sci Rep; 2020 Jul; 10(1):12101. PubMed ID: 32694570 [TBL] [Abstract][Full Text] [Related]
49. Integrin αvβ3 in the Mediating Effects of Dihydrotestosterone and Resveratrol on Breast Cancer Cell Proliferation. Ho Y; Li ZL; Shih YJ; Chen YR; Wang K; Whang-Peng J; Lin HY; Davis PJ Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326308 [TBL] [Abstract][Full Text] [Related]
50. Androgen Receptor in Breast Cancer-Clinical and Preclinical Research Insights. Anestis A; Zoi I; Papavassiliou AG; Karamouzis MV Molecules; 2020 Jan; 25(2):. PubMed ID: 31952272 [TBL] [Abstract][Full Text] [Related]
51. Zebrafish androgen receptor is required for spermatogenesis and maintenance of ovarian function. Yu G; Zhang D; Liu W; Wang J; Liu X; Zhou C; Gui J; Xiao W Oncotarget; 2018 May; 9(36):24320-24334. PubMed ID: 29849943 [TBL] [Abstract][Full Text] [Related]
52. Clinical significance of androgen receptor expression in triple negative breast cancer-an immunohistochemistry study. Liu YX; Zhang KJ; Tang LL Oncol Lett; 2018 Jun; 15(6):10008-10016. PubMed ID: 29844843 [TBL] [Abstract][Full Text] [Related]
53. Prenatal Exposure to Unconventional Oil and Gas Operation Chemical Mixtures Altered Mammary Gland Development in Adult Female Mice. Sapouckey SA; Kassotis CD; Nagel SC; Vandenberg LN Endocrinology; 2018 Mar; 159(3):1277-1289. PubMed ID: 29425295 [TBL] [Abstract][Full Text] [Related]
54. Differential requirements of androgen receptor in luminal progenitors during prostate regeneration and tumor initiation. Chua CW; Epsi NJ; Leung EY; Xuan S; Lei M; Li BI; Bergren SK; Hibshoosh H; Mitrofanova A; Shen MM Elife; 2018 Jan; 7():. PubMed ID: 29334357 [TBL] [Abstract][Full Text] [Related]
55. A systematic SNP selection approach to identify mechanisms underlying disease aetiology: linking height to post-menopausal breast and colorectal cancer risk. Elands RJ; Simons CC; Riemenschneider M; Isaacs A; Schouten LJ; Verhage BA; Van Steen K; Godschalk RW; van den Brandt PA; Stoll M; Weijenberg MP Sci Rep; 2017 Jan; 7():41034. PubMed ID: 28117334 [TBL] [Abstract][Full Text] [Related]
56. Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes. Kurozumi S; Yamaguchi Y; Kurosumi M; Ohira M; Matsumoto H; Horiguchi J J Hum Genet; 2017 Jan; 62(1):15-24. PubMed ID: 27439682 [TBL] [Abstract][Full Text] [Related]
57. Nuclear tristetraprolin acts as a corepressor of multiple steroid nuclear receptors in breast cancer cells. Barrios-García T; Gómez-Romero V; Tecalco-Cruz Á; Valadéz-Graham V; León-Del-Río A Mol Genet Metab Rep; 2016 Jun; 7():20-6. PubMed ID: 27114912 [TBL] [Abstract][Full Text] [Related]
58. Androgen Receptor Structure, Function and Biology: From Bench to Bedside. Davey RA; Grossmann M Clin Biochem Rev; 2016 Feb; 37(1):3-15. PubMed ID: 27057074 [TBL] [Abstract][Full Text] [Related]
59. Transfection of Sertoli cells with androgen receptor alters gene expression without androgen stimulation. Fietz D; Markmann M; Lang D; Konrad L; Geyer J; Kliesch S; Chakraborty T; Hossain H; Bergmann M BMC Mol Biol; 2015 Dec; 16():23. PubMed ID: 26715186 [TBL] [Abstract][Full Text] [Related]
60. CA1 contributes to microcalcification and tumourigenesis in breast cancer. Zheng Y; Xu B; Zhao Y; Gu H; Li C; Wang Y; Chang X BMC Cancer; 2015 Oct; 15():679. PubMed ID: 26459317 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]